Effect of Vibration Therapy on Hip Girdle Muscles in Healthy People
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Ju Seok Ryu, M.D. PhD
- Phone Number: +82-31-787-7739
- Email: jseok337@snu.ac.kr
Study Locations
-
-
Gyeonggi-do
-
Seongnam-si, Gyeonggi-do, Korea, Republic of, 463-707
- Recruiting
- Department of Rehabilitation Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine
-
Contact:
- Juseok Ryu, M.D, PhD
- Phone Number: +82-31-787-7739
- Email: jseok337@snu.ac.kr
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Healthy children (5 to 15 years old)
Exclusion Criteria:
- Children with cerebral palsy, muscle paralysis, developmental or congenital hip joint abnormalities
- Children who underwent hip joint surgery
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: 20 healthy children
20 healthy children aged 5 to 15 years , without any congenital or developmental abnormalities of their hip joint
|
After attaching the surface electromyography(EMG) to bilateral hip girdle muscles, participants will walk and jump at their comfortable speed.
After investigator record the muscle activation values, participants will be asked to stand on the vibration device.
While the whole-body vibration is applied, the hip girdle muscles activation values will be recorded accordingly via sEMG.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
muscle activation values on surface electromyography(sEMG)
Time Frame: 10 seconds for each session
|
surface muscle contraction of bilateral hip girdle muscles bilateral gluteus medius, tensor fascia lata, iliopsoas, rectus femoris muscles |
10 seconds for each session
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
VAS (Visual Analogue Scale)
Time Frame: 10 seconds for each session
|
a psychometric scale that is generally used in pain scale surveys and this study participants will be asked to scale the uncomfortable feelings during the vibration
|
10 seconds for each session
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Director: Ju Seok Ryu, M.D. PhD, Seoul National University Bundang Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- B-2212-801-305
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.